본문 바로가기
KERD
논문KCI 등재

한국형 양극성 장애 약물치료 알고리듬 2022: 노인

Korean Medication Algorithm Project for Bipolar Disorder 2022: The Elderly

1

조회

0

다운로드

0

인용

0

참고문헌

키워드

주제분류정신과학

초록

Objectives The fifth revision of the Korean Medication Algorithm Project for Bipolar Disorder (KMAP-BP) was undertaken to provide more precise guidelines for clinicians. In this study, we evaluated treatment strategies recommended by the KMAP-BP 2022 for theelderly patients with bipolar disorder. Methods The review committee comprised eighty-seven psychiatrists with vast clinical experience in treating bipolar disorders, who completed a survey. An expert consensus was obtained on pharmacological treatment strategies for elderly patients with bipolar disorders. The executive committee analyzed the data and discussed the results to produce the final algorithm. Results In elderly patients with bipolar disorders, the first-line treatment option for manic episodes is monotherapy, with atypical antipsychotics or mood stabilizers, and a combination of a mood stabilizer and atypical antipsychotics. The first-line treatment option for depressive episodes was a combination of a mood stabilizer and atypical antipsychotics, monotherapy with atypical antipsychotics or a mood stabilizer or lamotrigine, and a combination of atypical antipsychotics or a mood stabilizer with lamotrigine. Conclusion In the KMAP-BP 2022, the recommendation for treatment options for elderly patients with bipolar disorder, has been newly introduced. We expect that this algorithm would provide valuable information for the treatment of elderly patients with bipolar disorder

Abstract

Objectives The fifth revision of the Korean Medication Algorithm Project for Bipolar Disorder (KMAP-BP) was undertaken to provide more precise guidelines for clinicians. In this study, we evaluated treatment strategies recommended by the KMAP-BP 2022 for theelderly patients with bipolar disorder. Methods The review committee comprised eighty-seven psychiatrists with vast clinical experience in treating bipolar disorders, who completed a survey. An expert consensus was obtained on pharmacological treatment strategies for elderly patients with bipolar disorders. The executive committee analyzed the data and discussed the results to produce the final algorithm. Results In elderly patients with bipolar disorders, the first-line treatment option for manic episodes is monotherapy, with atypical antipsychotics or mood stabilizers, and a combination of a mood stabilizer and atypical antipsychotics. The first-line treatment option for depressive episodes was a combination of a mood stabilizer and atypical antipsychotics, monotherapy with atypical antipsychotics or a mood stabilizer or lamotrigine, and a combination of atypical antipsychotics or a mood stabilizer with lamotrigine. Conclusion In the KMAP-BP 2022, the recommendation for treatment options for elderly patients with bipolar disorder, has been newly introduced. We expect that this algorithm would provide valuable information for the treatment of elderly patients with bipolar disorder

참고문헌 (20)

  1. Weissman MM, "Affective disorders in five United States communities", Psychol Med, 18, pp.141~153 (1988)
  2. Dols A, "The prevalence of late-life mania : a review", Bipolar Disord, 16, pp.113~118 (2014)
  3. Sajatovic M, "A report on older-age bipolar disorder from the International Society for Bipolar Disorders Task Force", Bipolar Disord, 17, pp.689~704 (2015)
  4. Jon DI, "Revised Korean medication algorithm for bipolar disorder", World J Biol Psychiatry, 10(4 Pt 3), pp.846~855 (2009)
  5. Shin YC, "Korean medication algorithm for bipolar disorder : second revision", Asia Pac Psychiatry, 5, pp.301~308 (2013)
  6. Woo YS, "Korean medication algorithm project for bipolar disorder : third revision", Neuropsychiatr Dis Treat, 11, pp.493~506 (2015)
  7. Young Sup Woo, "Korean Medication Algorithm Project for Bipolar Disorder 2018 (KMAP-BP 2018): Fourth Revision", Clinical Psychopharmacology and Neuroscience, 16(4), pp.434~448 (2018), 대한정신약물학회[DOI]
  8. Sajatovic M, "Quetiapine for the treatment of bipolar mania in older adults", Bipolar Disord, 10, pp.662~671 (2008)
  9. Young RC, "GERI-BD : a randomized double-blind controlled trial of lithium and divalproex in the treatment of mania in older patients with bipolar disorder", Am J Psychiatry, 174, pp.1086~1093 (2017)
  10. De Fazio P, "Lithium in late-life mania : a systematic review", Neuropsychiatr Dis Treat, 13, pp.755~766 (2017)
  11. Sajatovic M, "Aripiprazole therapy in 20 older adults with bipolar disorder:a 12-week, open-label trial", J Clin Psychiatry, 69, pp.41~46 (2008)
  12. Yatham LN, "Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD)2018 guidelines for the management of patients with bipolar disorder", Bipolar Disord, 20, pp.97~170 (2018)
  13. Baruch Y, "Asenapine for elderly bipolar manic patients", J Affect Disord, 145, pp.130~132 (2013)
  14. Sajatovic M, "Asenapine in the treatment of older adults with bipolar disorder", Int J Geriatr Psychiatry, 30, pp.710~719 (2015)
  15. Madhusoodanan S, "Efficacy of risperidone treatment for psychoses associated with schizophrenia, schizoaffective disorder, bipolar disorder, or senile dementia in 11geriatric patients: a case series", J Clin Psychiatry, 56, pp.514~518 (1995)
  16. Shulman RW, "Treatment of elderly institutionalized bipolar patients with clozapine", Psychopharmacol Bull, 33, pp.113~118 (1997)
  17. Sajatovic M, "Efficacy of lurasidone in adults aged 55 years and older with bipolar depression: post hoc analysis of 2 double-blind, placebo-controlled studies", J Clin Psychiatry, 77, pp.e1324~e1331 (2016)
  18. Sajatovic M, "Multisite, open-label, prospective trial of lamotrigine for geriatric bipolar depression: a preliminary report", Bipolar Disord, 13, pp.294~302 (2011)
  19. Pacchiarotti I, "The International Society for Bipolar Disorders(ISBD)task force report on antidepressant use in bipolar disorders", Am J Psychiatry, 170, pp.1249~1262 (2013)
  20. Gildengers AG, "A 12-week open-label pilot study of donepezil for cognitive functioning and instrumental activities of daily living in late-life bipolar disorder", Int J Geriatr Psychiatry, 23, pp.693~698 (2008)

관련 논문AI추천

한국형 양극성 장애 약물치료 알고리듬 2022: 총론김원, 김문두, 박성용, 박원명, 서정석, 손인기, 심세훈, 양찬모, 우영섭, 윤보현, 이정구, 전덕인, 정명훈, 정종현, 추일한대한신경정신의학회 · 신경정신의학2022 · 제61권 제2호한국형 양극성 장애 약물치료 알고리듬 2022: 조증 삽화김원, 김문두, 박성용, 박원명, 서정석, 손인기, 심세훈, 양찬모, 우영섭, 윤보현, 이정구, 전덕인, 정명훈, 정종현, 추일한대한신경정신의학회 · 신경정신의학2022 · 제61권 제2호한국형 양극성 장애 약물치료 알고리듬 2022: 유지치료김원, 김문두, 박성용, 박원명, 서정석, 손인기, 심세훈, 양찬모, 우영섭, 윤보현, 이정구, 전덕인, 정명훈, 정종현, 추일한대한신경정신의학회 · 신경정신의학2022 · 제61권 제3호Korean Medication Algorithm Project for Bipolar Disorder 2022, Fifth Revision: An Executive Summary김문두, 박원명, 전덕인, 정명훈, 정종현, 추일한, Bo-Hyun Yoon, Chan-Mo Yang, Inki Sohn, Jeong Seok Seo, Jung Goo Lee, Se-Hoon Shim, Sung-Yong Park, Won Kim, Young Sup Woo대한정신약물학회 · Clinical Psychopharmacology and Neuroscience2022 · 제20권 제4호한국형 양극성 장애 약물치료 알고리듬 2022: 우울 삽화김원, 김문두, 박성용, 박원명, 서정석, 손인기, 심세훈, 양찬모, 우영섭, 윤보현, 이정구, 전덕인, 정명훈, 정종현, 추일한대한신경정신의학회 · 신경정신의학2022 · 제61권 제2호한국형 양극성 장애 약물치료 알고리듬 2022: 혼재성 양상김원, 김문두, 박성용, 박원명, 서정석, 손인기, 심세훈, 양찬모, 우영섭, 윤보현, 이정구, 전덕인, 정명훈, 정종현, 추일한대한신경정신의학회 · 신경정신의학2022 · 제61권 제2호

이 간행물의 다른 논문 (9건)